Valuation Neogen Corporation Boerse Muenchen
Stocks
NG2
US6404911066
Medical Equipment, Supplies & Distribution
|
Market Closed -
Boerse Muenchen
16:43:51 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 12.06 EUR | +1.22% |
|
+5.58% | +95.41% |
| 08-26 | Neogen Shares Rise After Piper Sandler Upgrade | MT |
| 08-26 | U.S. research roundup- Intuit, MongoDB, Zscaler | RE |
Company Valuation: Neogen Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,852 | 3,782 | 2,848 | 1,272 | 1,953 | 2,992 | - | - |
| Change | - | 32.58% | -24.68% | -55.35% | 53.52% | 53.22% | - | - |
| Enterprise Value (EV) | 2,852 | 3,782 | 2,848 | 1,272 | 1,953 | 2,992 | 2,992 | 2,992 |
| Change | - | 32.58% | -24.68% | -55.35% | 53.52% | 53.22% | 0% | 0% |
| P/E | 58.8x | -146x | -329x | -1.17x | -224x | -82.3x | -137x | -125x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 1x | 4.9x | -0x | 2.3x | -0x | 3.4x | -12.5x |
| Capitalization / Revenue | 5.41x | 4.6x | 3.08x | 1.42x | 2.24x | 3.39x | 3.46x | 3.34x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.39x | 3.46x | 3.34x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 16.7x | 15.6x | 15.1x |
| EV / EBIT | 0x | 0x | 0x | -0x | -0x | 251x | 117x | 127x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.45 | -0.12 | -0.04 | -5.03 | -0.04 | -0.1667 | -0.1 | -0.11 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 527.2 | 822.4 | 924.2 | 894.7 | 870.4 | 883.2 | 865.6 | 896 |
| EBITDA 1 | 82.31 | 205.4 | 213.2 | 184.2 | 177.8 | 179.6 | 191.5 | 198 |
| EBIT 1 | 58.62 | 37.52 | 58.66 | -1,061 | -21.6 | 11.9 | 25.47 | 23.5 |
| Net income 1 | 48.31 | -22.87 | -9.421 | -1,092 | -7.9 | -36 | -21.87 | -24.85 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 26.46 | 17.49 | 13.15 | 5.86 | 8.97 | 13.72 | 13.72 | 13.72 |
| Nbr of stocks (in thousands) | 107,797 | 216,221 | 216,608 | 217,038 | 217,673 | 218,056 | - | - |
| Announcement Date | 7/26/22 | 7/27/23 | 7/30/24 | 7/29/25 | 7/30/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.7x | 3.97x | 15.34x | 2.54% | 175B | |
| 18.75x | 3.44x | 12.31x | 3.18% | 113B | |
| 16.81x | 0.2x | 12.34x | 0.77% | 58.57B | |
| 35.42x | 3.42x | 11.72x | 2.13% | 50.07B | |
| 28.64x | 7.07x | 18.26x | 1.4% | 49.92B | |
| 34.72x | 6.1x | 19.16x | -.--% | 32.69B | |
| 45.51x | 1.29x | 11.97x | 0.21% | 30.44B | |
| 43.2x | 7.58x | 27.18x | 0.24% | 26.07B | |
| 54.38x | 7.25x | 23.3x | 0.39% | 23.55B | |
| Average | 34.01x | 4.48x | 16.84x | 1.21% | 62.22B | |
| Weighted average by Cap. | 29.06x | 3.98x | 15.27x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NEOG Stock
- NG2 Stock
- Valuation Neogen Corporation
Select your edition
All financial news and data tailored to specific country editions
